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ABSTRACT
Introduction: Effective local drug delivery to contractile tissues such as skeletal muscle
requires a thorough understanding of the impact of mechanical loads on intramuscular
pharmacokinetics. Current preparations for studying skeletal muscle biomechanics
typically use: mounting techniques that lead to mechanical disruption of the tissue, which
can create drug transport artifacts. In order to accurately study mechanical influences on
drug transport, experimental techniques and setups need to meet the particular design
requirements of both biomechanical testing setups and local drug delivery preparations.
Studies of intramuscular pharmacokinetics require anatomically physiologic and
functionally viable conditions for accurate drug transport. In this study, we invent a
method for the surgical isolation and mounting of whole skeletal muscles of small
rodents that maintains the physiologic configuration of the tissue. We also invent a
mounting assembly and dynamic loading system designed appropriately for in vitro drug
transport studies. We present an effective protocol for tissue processing and visually
quantifying intramuscular distribution of drug. With the primary objective of
investigating muscle pharmacokinetics, we use these techniques in a study to elucidate
the influence of mechanical loading on the intramuscular transport and distribution of
locally delivered drug.
Methods and Results: The dynamic loading system was characterized and used to
investigate intramuscular transport of aqueous macromolecular drug. The loading system
was designed to achieve a maximal force, velocity, and acceleration of up to 72N,
0.45m/s, and 8.5m/s 2, respectively, for imposing cyclic strain on soleus muscle samples.
Total compliance of the series assembly from the motor to muscle mounting blocks was
less then 0.0057 ± 0.002mm/N. Under proportional-integral-derivative (PID) control
with a positional resolution of 20gpm, the loading system achieved a positional precision
of +60gm or better for sinusoidal reference curves required in our studies. Tissue
architectural and functional integrity as well as a technique for quantifying intramuscular
fluorescent dextran were validated using the loading system. Histologic studies of rat
soleus showed that interstitial porosity was consistent in tissues subjected to mechanical
loading for 70 minutes, and changes in porosity were independent of the nature of
imposed static (0-15% fixed strain) and cyclic (3Hz sinusoidal strain with amplitude of
2.5% oscillating about mean strains of 5-15%) loads. Permanent changes in architectural
integrity depended only on the duration of time spent in vitro after isolation, in which
porosity increased at the tissue edge from 11.1 + 3.3% to 21.0 + 6.1% over the course of
a 70-minute incubation. The source solution used for local delivery of drug (dextran)
preserved tissue functional viability, allowing muscle samples to maintain isometric
twitch contractile activity at a rate of 3Hz for at least 1 hour. The active twitch force-
length characteristic of soleus samples showed 0.24 + 0.06N at 0% strain, a maximum of
0.35 + 0.06N at 10% strain, and a decrease to 0.19 + 0.06N at 20% strain. Isometric
twitch contractile force was at least 0.19N when measured every 15 minutes over a 2
hour period. Fractional volume of distribution for dextran was 84% of the bulk source
concentration over the range of 0.1 M-lmM bulk concentrations, and demonstrated the
non-binding properties of dextran. Fluorescence intensity of FITC-dextran equilibrated
in soleus tissue exhibited a linear dependence on dextran concentration. Dextran
penetration and distribution in soleus muscles under either cyclic (3Hz, 0-20% peak-to-
peak) or static (fixed at 0%) tensile strain for 80 minutes was quantified by fluorescent
imaging. Penetration depth of 1mM 20kDa FITC-dextran at the planar surfaces of the
soleus increased significantly from 0.52 + 0.09mm under static strain to 0.81 + 0.09mm
under cyclic strain. Penetration at the curved margins of the soleus was significantly
greater than at planar surfaces by a factor of 1.57 and 2.52 under static and cyclic strain,
respectively. Penetration at curved surfaces increased to a greater extent, by a factor of
1.6, than at planar surfaces under cyclic strain.
Discussion: This investigation demonstrated that dynamic, or cyclic, tensile strain
impacts the penetration and distribution of aqueous drug in skeletal muscle. In the course
of this study, we established an effective and robust experimental system and protocol for
studying mechanical influences on intramuscular pharmacokinetics. The innovation of
our surgical isolation and mounting technique allowed for the investigation of an isolated
soleus muscle without disrupting the muscle, tendons, or physiologic bone attachments.
The mounting device enabled muscles to be secured in a physiologic in situ
configuration, to undergo more physiologically distributed tensile stresses and strains,
and to be mechanically loaded while incubated in vitro in drug. Thus, the method and
device eliminated the artificial tissue stresses typically introduced by current tissue
handling techniques that could result in drug transport artifacts. While effective as a
standalone biomechanical testing preparation, characterization and validation of the
dynamic loading system with a protocol for tissue processing and quantitative assessment
of intramuscular fluorescent drug distribution demonstrated that it is a novel and robust
preparation for investigating both tissue biomechanics and pharmacokinetics. With the
finding from the present study that dynamic loading influences intramuscular drug
transport in an architecturally dependent manner, we intend to investigate the isolated
effects of different mechanical loading regimens on drug transport to establish a broader
understanding of muscle pharmacokinetics. It is hoped that the insights from this work
will guide the design and application of future local drug delivery strategies to
mechanically active tissues.
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1. INTRODUCTION
Muscle tissue presents an exclusive drug transport environment in which dynamic
mechanical motion and loading may be a predominant influence on the pharmacokinetics
of locally delivered agents. These motions and loads, which are shaped by both structure
and function of the muscle, can present significant dynamic physical influences on
aqueous drug transport by means of their effect on modulating extracellular space or fluid
distribution [1].
The effects of mechanical loading on the transport of local agents have been
investigated in a variety of mechanical tissues. Studies have examined the effects of
tension-compression on solute and dextran transport in cartilage [2-4], static tensile
loading on the diffusion of water in Achilles tendon [5, 6], and stretch on the transmural
transport of albumin, LDL, and Evans Blue dye in the arterial wall [7, 8]. Similar studies
in skeletal muscle have investigated the impact of contraction on the bulk uptake of
substrates like glucose [9, 10]. However, no studies have investigated the effects of
mechanical loading on the distribution and transport - not just the total uptake - of local
agents in the interstitial space of skeletal muscle. With the advent of local drug delivery,
and with the present clinically motivated need for effective strategies to locally deliver
therapeutic angiogenic growth factors to ischemic muscles [11], a quantitative knowledge
of the pharmacokinetics in muscle is critically important. Thus, the goal of this study is
to elucidate a fundamental understanding of the impact of mechanical loading on drug
transport in skeletal muscle.
Given that there are little data and prior experimental models in the literature on
this topic, we present an innovative experimental approach and associated system of
devices designed to determine the impact of mechanical loading on aqueous drug
transport in muscle. The approach and devices integrate the specific design requirements
of both biomechanical testing and in vitro drug delivery preparations.
Preparations for studying whole skeletal muscle biomechanics have involved
invasive procedures using both in situ and in vitro preparations. However, the surgical
isolation and muscle mounting methods typically used in these studies disrupt the
physiologic anatomy and configuration of the intact muscle bundle. Most isolation
techniques leave the tendons on a muscle, such as the soleus, intact so that they may be
used for mounting. However, this also eliminates any support provided by bony
attachments that helps to maintain the physiologic configuration of the muscle-tendon
unit and thereby affects the physical dimensions and force transmission through the
muscle bundle. While other isolation techniques leave a small piece of calcaneus
attached to the distal tendon, the piece serves only as an anchoring point to prevent
slippage of suture tying the tendon [12, 13] and is not used for mounting the muscle in a
physiologic configuration. And, the few techniques that actually use the bony
attachments for mounting do so without an adequate means of fixing the bone segment to
secure the orientation of the tissue [14, 15].
Current mounting methods applied on the intact tendon or directly on the muscle
itself rely mostly on suture thread or wires [12, 13, 16-19], chains [20], clamps [21-23],
pins [24-26], hooks [14, 27, 28], or fixing rods [14] to hold the samples in place.
However, few of these techniques maintain physiologic tendon or muscle bundle
configuration rigorously enough for studies of intramuscular drug transport, which
require physiologic architecture and functional force transmission to be preserved. By
their very mechanism, sutures, chains, and clamps distort tendon and muscle anatomy,
hooks disrupt muscle integrity and mechanical continuity, and fixing rods do not insure
that bone-tendon orientation is accurately recreated or maintained.
Such architectural disruption of the tissue during surgical isolation and mounting
may result in drug transport artifacts because drug transport and distribution depend
highly on the architectural state of the target tissue. In the case of a mechanically active
tissue such as muscle, in which mechanical function and architectural configuration are
intimately related [29], architectural disruption furthermore disrupts mechanical
properties and performance, whose impact on drug transport and distribution is the
primary focus of this study. Consequently, these traditional experimental preparations
are inadequate for studies of intramuscular pharmacokinetics under mechanical loading.
Pharmacokinetic studies that seek to quantify and visualize the intramuscular distribution,
and not simply the total uptake, of drug require isolation and mounting methods that
more rigorously maintain both the physiologic architecture and mechanical function of
muscle.
Additionally, accurate drug transport requires functional viability of tissues.
Because viability dictates both architectural integrity and mechanical function of
muscles, a further requirement for pharmacokinetic studies is a local drug delivery
setup that effectively maintains functionally viable and mechanically active tissue. In
situ preparations for electrophysiological studies have been devised to immerse muscles
in solution by forming a pocket out of overlying skin flaps [12, 15, 20, 30-32]. Such
preparations offer a feasible method to incubate tissues in drug as well as the advantage
of maintaining muscle viability and physiologic configuration. However, they would be
ineffective for local drug delivery as surrounding tissues forming the pocket would
absorb drug and alter the concentration of the source bath. Moreover, in situ preparations
typically require elaborate and inconvenient stereotaxic setups [12, 13, 15, 20, 30, 31,
33]. Therefore, a convenient and effective preparation for both mechanical testing and
local drug delivery to muscles under architecturally physiologic and functionally viable
conditions is required.
In the present study we invent a tissue handling approach and associated
mechanical loading system designed suitably for drug transport studies and use this
system to investigate the transport and distribution of locally delivered, aqueous
macromolecular drug in skeletal muscle under mechanical loading. The study of accurate
drug transport requires particular handling of tissue samples to avoid introducing
disturbances to architectural integrity and functional viability that could result in
transport artifact. Therefore, our tissue handling approach consists of a method for
surgical isolation, explantation, and mounting of small rodent soleus muscles that allows
for investigating tissue mechanics without disrupting the muscle, its tendons, or
physiologic bone attachments, and without loss of physiologic dimensions and tone. The
mechanical loading system consists of a mounting assembly and dynamic loading system
for investigating intramuscular transport of locally delivered drugs in association with
control of muscle biomechanics. The innovation of the technique and associated
mounting assembly allows muscles to be held in a physiologic configuration. This
enables muscles to undergo more physiologically distributed tensile strains and stresses
as they would experience in an in situ configuration, thereby eliminating artificial tissue
stresses imposed by regular handling methods such as sutures, hooks, or clamps that
could introduce drug transport artifacts. The loading system enables dynamic mechanical
testing to be performed on physiologically mounted tissue samples while they incubate in
an in vitro drug bath that maintains muscle functional viability. Along with this system,
we present a protocol for tissue processing and visually quantifying intramuscular
distribution of fluorescent drug. We validate and use the experimental approach and
system in our primary aim to study muscle pharmacokinetics to determine whether cyclic
tensile loading affects drug transport in soleus tissues.
2. DESIGN OF A TISSUE HANDLING TECHNIQUE AND MECHANICAL
LOADING SYSTEM
2.1 General Description
This is a method for the surgical isolation and mounting of isolated, whole soleus
muscles of small rodents, as well as the associated mounting assembly and dynamic
loading system designed for investigating the intramuscular transport of locally delivered
drugs under mechanical loading. The method and mounting device are uniquely
designed for mounting isolated muscle in a physiologic in situ configuration without
physical disruption to the soft tissues or bone attachments in order to eliminate
experimentally imposed mechanical sources of drug transport artifacts. The method and
mounting device are also robust enough to be incorporated into existing preparations or
setups used in general studies of muscle biomechanics. The dynamic loading system
enables biomechanical testing to be performed on muscle samples while they are
immersed in a drug bath, under functionally viable conditions, and thereby delivers the
diverse functional capabilities of both biomechanical testing and in vitro drug delivery
preparations.
2.2 Surgical Isolation Protocol
Male Sprague-Dawley rats weighing 450-470g are administered 1000U of
Heparin via intraperitoneal injection 5 minutes prior to euthanasia with inhaled carbon
dioxide. Thoracotomy is performed immediately after euthanasia, and 60ml of Krebs-
Henseleit-BDM (KH-BDM) solution (118.1mM NaCl, 4.7mM KC1, 2.5mM CaC12,
1.2mM MgSO 4, 1.2mM KH 2PO4, 25mM NaHCO3, 11.1mM Glucose, supplemented with
1mM Sodium Pyruvate, ImM Isoleucine, ImM Leucine, lmM Valine, and 5mM
butanedione monoxime (BDM) at pH 7.4) that is oxygenated with 95% 02 / 5% CO 2 gas
mixture is infused down the aorta to relax and preserve the tissues of the lower body of
the rat during the surgery.
The soleus is surgically exposed in one of the distal hindlimbs. The skin is
opened by sharp dissection. The overlying gastrocnemius and plantaris are separated
from the soleus and excised by both sharp and blunt dissection. Fascial connections are
dissociated from the soleus by blunt dissection. The tendon attachments of the overlying
muscle bundles at the tuber calcanei and the head of the fibula are dissociated from the
tendons of the soleus. The length of the soleus muscle is measured in situ between its
proximal and distal myotendinous junctions while flexing the knee and ankle joints at
900. In our study, this in situ length is referred to as the nominal length, and was
measured using a Mitutoyo Digimatic caliper with a precision of +0.01mm.
The calcaneus is then resected from the foot by separating it from its ligamentous
attachments to the talus, cuboid, navicular, and 5 th metatarsal. The tuberosities on the
calcaneus are trimmed away using bone cutters. The soleus is gently lifted from
underlying muscle bundles - the peroneus longus and flexor hallucis longus - as fascial
connections to these muscles are cut by sharp dissection. This procedure also detaches
the soleus from the diaphysis of the fibula. While holding the soleus away from the rest
of the limb, the diaphysis and proximal epiphysis of the fibula are separated from
surrounding muscle by sharp dissection. The head of the fibula is sheared from the
lateral condyle of the tibia. The fibula is then broken at mid-diaphysis to complete the
resection of the soleus muscle along with its tendinous attachments, the head of the
fibula, and the tuber calcanei still intact.
During surgical isolation and extraction, the soleus is superfused with KH-BDM
to prevent drying. The surgical isolation procedure is then repeated for the soleus of the
contralateral limb while the first excised soleus is held at its nominal length using the
mounting assembly while sitting in regular Krebs-Henseleit (KH) loading solution
(118. I1mM NaC1, 4.7mM KC1, 2.5mM CaC12, 1.2mM MgSO 4, 1.2mM KH 2PO4, 25mM
NaHCO3, 11.1mM Glucose, supplemented with 1mM Sodium Pyruvate, ImM Isoleucine,
1mM Leucine, and ImM Valine at pH 7.4) that is oxygenated with 95% 02 / 5% CO 2 gas
mixture and chilled on ice.
2.3 Mounting Configuration
The excised whole muscle bundle plus its tendons and bone segments are fixed
onto the mounting blocks by inserting the bone segments into angled slots in the blocks
(Figure 1). The slots secure the bone segments by mechanical fit and leverage, which
holds the segments at an acute angle in relation to the axis of the muscle without the need
for additional fastening mechanisms. The mechanical fit prevents slippage and rotation
of the specimen, and leverage on the bones enables them to transmit tensile forces to the
tendons and muscle. The blocks and mounting configuration maintain the in situ
orientation of the myotendinous junctions and tendinous attachments with respect to the
bone segments. The mounting blocks suspend the soleus muscle between its two ends in
an in situ configuration via its own physiologic attachments, preserve the physical
dimensions of the muscle, and eliminate any disruption or distortion to the muscle or
tendons. The mounting blocks enable tensile force to be applied to only the bones, and to
be transmitted to the muscle through its tendinous attachments without the use of sutures,
hooks, or clamps.
Tensile Force
Calcaneus
Figure 1. Mounting configuration and blocks. A) The mounting configuration of the
isolated soleus and its natural bone attachments in the mounting blocks. The mounting
blocks secure the bone segments at an acute angle in relation to the axis of the muscle
without disruption to the muscle or tendons by sutures, hooks, or clamps. Tensile force is
transmitted from the bone segments to the muscle in a physiologic manner to preserve
tissue dimensions and configuration. B) The Solidworks design and rendering of the
mounting blocks. The physical design and orientation of the slanted slots in the mounting
blocks enables them to secure bone segments in place without the use of fixtures. C) A
cross-sectional view of the mounting blocks showing the internal course of the slanted slots
through the blocks (arrows).
2.4 System Design Considerations
Materials selection and motor sizing for the dynamic loading system were
determined based on numerical simulations of the passive material properties of muscle
in response to externally applied changes in length. A one-dimensional, lumped-
parameter, viscoelastic model of resting muscle was used to simulate the passive force
response to both step and cyclic uniaxial mechanical strain. The validity of a one-
dimensional model is based on the uniformity of both the cross-sectional geometry and
mechanical properties along the length of the uniaxial muscle (soleus) used
experimentally.
The model consists of two viscoelastic units (K1, C1 and K2, C2) both coupled in
parallel with an elastic element (Ko), and in series with an inertial mass (M) (Figure 2).
Values from the literature for muscle length, 10mm (20mm - 2 for symmetrical motion
of the mounting blocks in the dynamic loading system) and cross-sectional area, 20mm 2,
as well as muscle mass plus estimated inertial mass of the mounting blocks, 200g, were
used in the model along with the elastic and viscous parameter values from Loeffler, et.
al. [34] In these simulations, length perturbations to no more than 20% of the muscle
length were used for both the step and sinusoidal strain inputs to probe the properties of
the resting muscle.
The lumped-parameter model was simulated in Matlab. The passive tension
developed by the muscle in response to a step change in length was simulated in the time
domain. The frequency response of the muscle to sinusoidal length perturbations was
simulated using a state space characterization of the model. The Bode plot generated for
the frequency response shows the magnitude conversion factor between the perturbation
input and force output of the muscle, as well as the phase response, over a range of
frequencies (Figure 2D). Matlab source codes for these simulations are shown in
Appendix A.
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Figure 2. Model of resting muscle response to length perturbations. A) The one-
dimensional, lumped-parameter, viscoelastic model of resting muscle used for materials
selection and motor sizing of the dynamic loading system. B) The parameter values for the
viscous, elastic, and mass elements used to simulate the model. C) Passive tension developed
in response to a step in length change of 2mm. Peak passive force developed was 6N. D)
Frequency response. The magnitude conversion factor at 3. Thus, a 2mm perturbation
input at 3Hz yields a 5.4N force response.
The upper bound force requirements for the loading system were determined
using the passive force response to a 2mm step in length change (20% strain of a 10mm
length of muscle), and frequency response to a 2mm perturbation at 3Hz frequency (the
maximum rate required in our loading experiments). These peak forces were 6N and
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5.4N, for the static and cyclic strain conditions, respectively. Upper bound velocity and
acceleration requirements were determined using a sinusoidal displacement profile with
3Hz frequency and 2mm amplitude. These forces, velocity, and acceleration were used
with a factor of safety of 2 and sample number of 6 to specify peak performance
requirements for the motor. The requirements for peak force, velocity, and acceleration
were determined to be 72N, 0.45m/s, and 8.5m/s 2, respectively.
2.5 Mechanical Loading System
The mechanical loading system is designed to allow for the study of isolated
muscle bundles in a physiologic in situ configuration, with intact myotendinous and
tendinous-bony junctions. The system consists of two major components: 1) corrosion
resistant mounting blocks and 2) a dynamic loading system. Designs and drawings of the
components in the system were made using Solidworks and are shown in Appendix B.
The pair of conjugate mounting blocks suspends a pair of soleus muscles by their
physiologic bone attachments while maintaining the muscles in an in situ configuration
and preserving architectural dimensions. The mounting blocks provide an independent
means for holding muscle specimens and are robustly designed to be applicable in
general biomechanics studies and incorporated into existing setups or preparations. In
this study, the mounting blocks can be secured in a "fixed," or static, mounting assembly
as a standalone device to provide an independent means to impose static tensile loading at
user-defined fixed strains on muscle samples (Figure 3). Or, they can be disengaged
from the fixed assembly and individually attached onto the dynamic loading system to
serve as mounting fixtures that hold samples for automated dynamic, or cyclic, tensile
loading (Figure 4).
The static mounting assembly may be used on muscle samples for imposing static
strain; investigating passive tensile force; or measuring isometric or isotonic contraction
force, velocity, or displacement. The assembly allows for static tensile loading to be
performed in either a horizontal or vertical orientation, and specifically enables the
muscle samples to be immersed in select media and incubated in a well-stirred and
oxygenated solution during loading. The assembly can also accommodate the attachment
of weights (when orientated vertically) and load cells or force transducers.
The dynamic loading system imposes automated, cyclic or oscillatory, and high
force loads on mounted samples. It features the full functionality of a biomechanical test
instrument with the unique capability to implement its mechanical utilities while tissue
samples are immersed in well-stirred and oxygenated media or maintained in a local drug
delivery preparation. The system is driven by a linear motor but is designed to
accommodate a range of driving sources, such as a linear motor, rotary motor with cam
or belt drive, or ball screw drive for actuating the mechanical loading of samples. The
loading arrangement can be configured to impose isotonic, isometric, eccentric, or
concentric strain. Strain can be imposed either symmetrically or asymmetrically through
independent control of the displacement and fixation of the two mounting blocks. These
different configurations allow for potential measurement of tensile forces using a load
cell that can be attached to the loading system or of strain of the sample by quantifying
the displacement of the mobile block. The loading setup can be orientated for loading to
be performed along either a horizontal axis (for drug delivery studies on incubated
samples) or a vertical axis (for applying dynamic loads with the option of attached
weights on non-incubated samples).
2.5.1 Mounting Blocks and Static Assembly
The following descriptions with Roman numbering refer to the labels in Figure 3.
Two Polycarbonate (Lexan) blocks of equal size are each machined with 2 primary
through-holes that run at a 100 angle from the top surface of the block (i) to serve as the
mounting holes for bone segments. These holes on each block are sized to fit the
respective bone (fibula or calcaneus) that they secure to insure a proper mechanical fit
with the bone. A pair of tapped through-holes (ii) on each block that run from the top to
the bottom surface of the block offer the option of attaching clamping bars to secure the
bones to the block. The use of bar clamps also serves as an option for further securing
the samples but is unnecessary for most general purposes.
For use in the static mounting assembly, each block is machined with a pair of
through-holes (iii) that run in the direction of the axis of the muscle samples. Stainless
steel rods (iv) pass through these holes and co-align the two blocks. The rods serve as
guide-rails for the two blocks to slide on during axial displacement. Set screws that
engage the guide-rails are used to lock the Lexan blocks at user-defined fixed positions
along the guide-rails. Each block is further machined with a center through-hole (v) that
also runs in the direction of the axis of the samples. This hole is tapped in the fibula
mounting block but untapped in the calcaneus mounting block. These two holes allow a
#8-32 thread lead screw (vi) to be used to set and fix the separation distance of the blocks
with respect to each other. The lead screw is held in place in the calcaneus block by
locknuts (vii) and adjusts the displacement of the fibula block with a resolution of 0.8mm
per turn. The lead screw can also be locked in a fixed position by a set screw to fix the
separation distance of the two blocks. A set of through-holes (viii) that run from top to
bottom allow for the attachment of the mounting blocks to the motor-actuated, dynamic
loading system. Figure 3 shows the mounting blocks in the static assembly and with
soleus muscles mounted.
Figure 3. Static mounting assembly. The mounting blocks hold and maintain physiologic
configuration of muscle samples using their natural bony attachments as strain transmitters
rather than as restraining devices alone. A) Design of the mounting blocks. Slanted
through-holes are sized appropriately for the bone segment (fibula or calcaneus) that they
secure. B) The fixed, or static, mounting assembly applies static tensile strain on mounted
muscle samples. C) Soleus muscles are mounted by securing the calcaneus and fibula
without the use of fixtures. Strain can be applied while the samples are immersed in select
media and incubated in a well-stirred and oxygenated solution. D) The simple mounting
method allows muscles to incubate in a minimal volume of solution to conserve drug source
and avoid the use of excessive, suprapharmacologic doses in transport studies. The fixed
assembly can be disassembled and the mounting blocks used as the mounting fixtures in the
dynamic system.
A tapped through-hole (ix) at the centerline of the fibula mounting block enables the
block to be attached to a support (to a wall if aligned along a horizontal axis of
displacement, or to an overhanging structure if aligned along a vertical axis of
displacement), to a weight (for applying constant force along a vertical axis), or to a load
cell.
2.5.2 Dynamic Loading System
The following descriptions with Roman numbering refer to the labels in Figure 4.
Similar to the design of the fixed mounting assembly, 2 stainless steel guide-rails (i) co-
align 2 equally sized Lexan sliding blocks (ii) that run on the rails by means of ceramic
bearings (iii). The ceramic bearings reduce the kinetic friction of the sliding blocks to
facilitate their cyclic motion during dynamic loading. The guide-rails are locked into
support brackets (iv) at either end by means of slotted spring pins (v). This entire unit,
consisting of sliding blocks, guide-rails, and support brackets, is mounted atop a platform
base, on which is also fixed the linear motor (vi) that actuates the cyclic loading. The
motor is mounted to the platform base by means of its mounting flange.
The rotor, or slider, of the linear motor runs through a center hole in one of the
support brackets to attach to the outer side of one of the Lexan sliding blocks (vii). The
sliding block is attached to end of the slider, which has a threaded borehole on its end, by
means of a M8 hex screw (viii). An oversized screw hole is machined in the sliding
block to compensate for any errors in axial alignment between the block and the end of
the slider. Care was also taken to prevent or compensate for errors in parallelism
between the sliding blocks and the linear motor by means of precisely aligning the guide-
rails and the linear motor during design, manufacture, and assembly of the system.
The opposite sliding block has a tapped through-hole (ix) that allows for it to be
fixed to the support bracket or to a force transducer that may be attached to the support
bracket. A rack and pinion assembly is situated at the midpoint of each guide-rail by set
screws (x). The pinion rotates about a shaft fixed to the guide-rail and a rack is fixed to
each sliding block on either side. This assembly enables the symmetric displacement of
the sliding blocks about the midline of the guide-rails. It also actuates the coordinated
and simultaneous motion of both sliding blocks while only one is driven by the linear
motor. This rack and pinion assembly can be disengaged, and one sliding block can be
fixed to the support bracket or a force transducer that is attached to the support bracket
while the other sliding block is driven by the linear motor to enact asymmetric
displacement of the sliding blocks. Each sliding block has a pair of tapped holes
machined on its underside for the attachment of a mounting block. The mounting block
can be attached to the sliding block either flush or offset by a connecting block (xi) and
spacers. The offset configuration shown in Figure 4D and 4E enables the mounting
blocks and suspended muscle sample to be immersed in superfusate solution during
cyclic loading. When the mounting blocks are attached to the dynamic setup, the guide-
rails and lead screw from the fixed assembly are removed, and displacement of the
mounting blocks is driven by the linear motor.
Figure 4 (A-F). Dynamic loading system. A) A PID-controlled linear servo motor actuates
dynamic strains on mounted muscle specimens. B) The rack and pinion assembly for
actuating symmetrical displacement of the sliding blocks. This can be disengaged to enable
asymmetrical displacement of the blocks, and for the attachment of a load cell on one side
so that force measurements can be made. C) Each sliding block has a connecting block for
attaching and offsetting one of the individual mounting blocks shown in Figure 3. D) When
attached to the sliding blocks via the connecting blocks, the mounting blocks are positioned
in the same configuration as when they are in the static assembly. Without the guide-rails
and lead screw of the static assembly, the mounting blocks are free to translate according to
the motion executed by the motor. E) Mounted soleus muscles can be suspended in a
superfusate bath while mechanical loading is performed. F) In the experimental setup for
applying either static or dynamic loading, mounted samples are stretched while incubated
in well-mixed and oxygenated drug solution at room temperature.
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Figure 4 (G-H). G) Solidworks rendering of the dynamic mounting assembly with
mounting blocks attached. This assembly is mounted atop the platform base. H)
Solidworks rendering of the dynamic loading system.
2.5.3 Motion Actuation and Control
The cyclic mechanical loading of the sliding blocks is actuated by a LinMot®
PO1-37x240/60x260 linear servo motor that is controlled by a LinMot® El 00-MT servo
controller. A linear motor is used as the motion control element to simplify the design
and enable linear stroke motion to be directly applied to the sliding blocks without the
use of mechanical gears, belts, or ball screws; conventional pneumatic cylinders; or
mechanical constructions based on levers, spindle drives, cam disks, belts, etc. The direct
actuation provided by a linear drive improves accuracy and precision by minimizing
mechanical play, reducing compliance, and avoiding wear of multiple additional
elements. The LinMot® P motor consists of a fixed stator housing with 2 two-phase
windings and a moveable slider containing neodymium magnets. This motor is an
electromagnetic, direct, linear driver with fully integrated, contact-free, Hall effect,
position sensors and bearings that enable it to execute dynamic, position-controlled,
linear movements easily and directly to the load. Furthermore, because motion control of
this mechatronic drive system is defined exclusively in the LinMot® software, a diverse
range of linear loading protocols can be selected, adjusted in real-time, and executed
without the need for altering the physical setup.
Motion control - including actual machine functionality, loading protocol, and
motion parameters - is performed by the El 00-MT servo controller, which also supplies
power to drive the motor. The controller regulates all control and monitoring actions
necessary for controlling the motor. It saves and loads stored motion profiles and
parameters from an overlaid control system. An integrated digital position control
system enables the E00-MT to drive the motor smoothly to desired positional setpoints
using proportional-integral-derivative (PID) controller logic and feed-forward
anticipatory compensation. Feed-forward control includes three anticipatory parameters
with which the control behavior and hence the attainable dynamics can be improved.
These compensate for sliding friction, accelerating load, and decelerating load. Thus,
PID control and feed-forward compensation enable the system to achieve very robust,
repeatable, and accurate execution of a desired motion profile even in the presence of
external disturbances, and corrects any static controller deviations.
Configuring and commissioning of the LinMot@-E servo controller is performed
using LinMot® Talk, a Microsoft Windows-based software program. LinMot® Talk
supports a modular graphical interface with menus that enable the user to define motion
profiles and to configure, command, and monitor the linear motor in real-time. On-line
measurements of motor data and movements made by the controller can be shown in
graphical form and stored on the computer. The software thus enables complex test
routines to be performed for biomechanics studies. In this study, a sinusoidal motion
profile was defined and run continuously for dynamic loading of soleus samples.
3. METHODS
3.1 Characterization of Dynamic Loading System
3.1.1 System Compliance
Mounting blocks were attached to the sliding blocks of the dynamic loading
system in the symmetric loading configuration. Stainless steel guide-rails were inserted
into the mounting blocks as they would be in the static assembly and locked into place by
their designated set screws, thereby fixing the positions and separation distance of the
mounting blocks. The linear motor imposed sinusoidal positional profiles with
amplitudes of 0.125mm, 0.25mm, and 0.5mm on this locked assembly. Displacement
and force generated by the motor were recorded by the motor's internal position sensor
and encoder and used to calculate the compliance of the loading system.
3.1.2 Motor Tuning
The dynamic performance and positional accuracy of the motor were optimized
for applying cyclic strain profiles used our in transport experiments by tuning the PID
controller under maximal performance conditions. With 2 soleus muscles of 28mm
nominal length mounted in the symmetric loading configuration, the linear motor
imposed a reference sinusoidal positional profile with 0.35mm amplitude and 3Hz
frequency to simulate upper bound performance conditions in our transport studies. The
PID controller parameters were tuned in real-time during continuous actuation such that
proportional, integral, and derivative control were maximized to optimize motor response
time, minimize tracking error and positional overshoot during acceleration and
deceleration, and eliminate steady state positional error while not causing motor
oscillations lor positional instabilities. The reference and actual position of the motor was
monitored in real-time during continuous actuation using the internal position sensor of
the motor, which has a 20tm resolution, and recorded using the oscilloscope utility
included in LinMot® Talk to characterize performance. The optimal PID parameters
found by this test were used in all subsequent loading experiments.
3.2 Evaluation of Tissue Properties
3.2.1 Architectural Integrity
Changes in the architectural integrity of soleus muscles developed in vitro under
the range of loading regimens imposed by our transport experiments were assessed
histologically. Because rats were selected in a narrow weight range, all soleus muscles
used in the experiments in this investigation were of uniform size and measured 28mm in
nominal length. Isolated muscles underwent mechanical loading for 70 minutes while
they incubated in a superfusate bath of KH oxygenated with 95% 02/5% CO2 at room
temperature. All experiments in this study were performed at room temperature, which is
most favorable for the simultaneous investigation of both muscle biomechanics and drug
transport. Room temperature is optimal for maintaining the viability and physiologic
stability of muscles in vitro [35] without loss or inhibition of drug binding or transport
properties. Room temperature furthermore enhances muscle endurance [36] and
economy of substrate turn-over [37] during contractile performance, while maintaining
the physiologic force-length relationship and contractile capacity of the muscle [37, 38].
Samples (n=6) underwent a range of magnitudes of static or dynamic straining
conditions. Static loading cases underwent 0%, 5%, 10%, or 15% strain. Dynamic
loading cases underwent maximal loading conditions. Sinusoidal strain of 3Hz frequency
and 2.5% strain amplitude was applied at mean strains of 5%, 10%, or 15%. In this
study, 0% strain corresponds to the measured in situ nominal length, 5% strain
corresponds to a muscle length that is 105% of the nominal length, etc. After mechanical
loading, tissues were snap-frozen at nominal length while mounted on the static assembly
in Isopentane chilled to -145°C in liquid nitrogen. 8p.m thickness axial cross-sections
from the midpoint of the soleus samples were cut using a Leica CM 1850 cryotome and
stained with Hematoxylin and Eosin. Light microscopy images of the sections were
taken at 40X magnification. Image processing was performed using Matlab. The size
and shape of soleus muscle fascicles were qualitatively assessed. The tissue porosity, or
relative area of the interstitial space between muscle fibers and fascicles, was quantified
as a percentage of the total area of the section and used as a measure of tissue structural
integrity.
3.2.2 Functional Viability
The functional viability of soleus samples under in vitro conditions was assessed.
Soleus samples (n=6) were held at their in situ nominal length by the static assembly and
incubated in a KH bath oxygenated with 95% 02/5% CO2 at room temperature. Samples
were continuously paced by electric field stimulation to induce isometric twitch
contractions at a rate of 3Hz for 1 hour. This was done to assess the presence and
persistence of contractile activity and functional viability under the maximal performance
requirements and through the duration of a transport experiment. The electric stimulus
was a biphasic voltage output of 15V amplitude and 50ms pulse duration applied by 2
stainless steel foil plates situated at either end of the static assembly, spanning a
separation distance of 10cm (Figure 5A). Electric stimulus was generated using a
National Instruments DAQPAD-6062E data acquisition board and controlled by its
Arbitrary Waveform Generator virtual instrument.
Figure 5. Mounting configurations for assessing functional integrity. A) Isometric twitch
contractions were electrically paced at 3HIz for 1 hour by field stimulation to assess the
presence and persistence of functional viability under the maximal performance
requirements of transport studies. B) Active twitch and passive force-length relationships
were quantified using a modified configuration of the static assembly that incorporated a
force transducer.
Force measurements of soleus samples were separately recorded using a modified
configuration of the fixed assembly (Figure 5B). A thin-beam load cell (Omega
Engineering, Inc., LCL-227G, 0-227g) secured to one of the guide-rails was attached to
the fibula mounting block, which was allowed to slide freely. The calcaneus block was
fixed in position to the guide-rails by set screws. Soleus muscles (n=7) were individually
mounted and stimulated to produce isometric twitch contractions at their in situ nominal
length using a biphasic voltage output with 15V amplitude and 50ms duration applied to
the tendons using stainless steel electrodes. Active twitch tension was measured every 15
minutes over a period of 2 hours. Between force recordings, muscle samples were kept
fresh by incubating in KH superfusate oxygenated with 95% 02/5% CO2 at room
temperature.
3.2.3 Force-Length Relationships
Muscles (n=7), 28mm in nominal length, were individually mounted on the force
measurement configuration of the static assembly and stimulated to produce isometric
twitch contractions using a biphasic voltage output with 15V amplitude and 50ms
duration applied to the tendons using stainless steel electrodes. Each muscle was pre-
strained over a range of fixed strains (0%, 5%, 10%, 15%, and 20%), and passive and
total tension developed during contractions were measured at each strain. Developed
active twitch force at each strain was calculated by subtracting passive from total tension.
Between force recordings, samples were kept fresh by incubating in KH superfusate
oxygenated with 95% 02/5% CO 2 at room temperature.
3.3 Quantification of Drug Transport
3.3.1 Fractional Volume of Distribution
Fractional volume of distribution of FITC-dextran (Sigma, Catalog # FD4, 4kDa
MW), our model drug, in soleus tissue was determined through equilibrium incubation
studies. The time course of dextran equilibration, which was achieved when the time rate
of increase or decrease of drug concentration in the incubated tissue reached zero, for
incubation and elution was first determined. Equilibration time for elution of dextrans
from pre-incubated soleus samples was first quantified. Soleus (n=5) samples of 50mg
mass and 4-5mm maximal thickness, which were pre-incubated in 10mL of 1mM
concentration 4kDa FITC-dextran in PBS for 5 days, were incubated in 10mL volumes of
fresh PBS for a range of time points (0, 0.5, 1, 3, 8, 13, 24, 50, 74, 98, or 130 hours). At
each elution time point, 100IL of the bulk PBS was sampled and fluorescence was
quantified using a ThermoLabsystems Fluoroskan Ascents FL microplate fluorometer
(ex: 485nm / em: 538nm) in order to determine the amount of dextran eluted out of the
soleus sample by each time point. The time for elution concentration to reach
equilibrium, or steady state, was determined when fluorescence intensity of the bulk no
longer increased.
Equilibration time for uptake of dextran by soleus samples was then quantified.
Soleus (n=5) samples of 50mg mass and 4-5mm maximal thickness were incubated in
10mL volumes of 1mM or 0.1mM concentration 4kDa FITC-dextran in PBS for a range
of time points (0, 6, 8, 12, 24, or 60 hours). At each incubation time point, muscle
samples were removed from the dextran solution, blotted on dry towels, and immersed in
10mL of fresh PBS until elution of dextran reached equilibrium, as determined by the
elution experiment. Fluorescence of the eluate was quantified in order to calculate the
total amount of dextran uptaken by the sample by each incubation time point. The time
for uptake concentration in the tissue to reach equilibrium was quantified.
Based on the equilibration times for uptake and elution, the fractional volume of
distribution for dextran in soleus muscle was determined for a range of bulk source
concentrations of dextran. Soleus (n=6) samples of 20-30mg mass and 4-5mm maximal
thickness were incubated to equilibrium in 10mL volumes of 0. lpM, 1pM, 0.01mM,
0.1mM, or ImM bulk source concentrations of 4kDa FITC-dextran in PBS. After
equilibration, each specimen was blotted on dry towels and immersed in 10mL of fresh
PBS until elution of dextran reached equilibrium. Fluorescence of the eluate was
quantified and used to calculate the equilibrium tissue concentration achieved by uptake.
An equilibrium distribution relationship, which characterizes the distribution of drug
through tissues incubated to equilibrium in bulk phase concentrations of drug, was
constructed by plotting the concentration of drug in the sample versus the concentration
in the corresponding bulk source. Fractional volume of distribution of the muscle, which
is the ratio of the tissue concentration to bulk concentration, was determined from the
slope of the equilibrium distribution relationship.
3.3.2 Drug Transport Under Mechanical Loading
Soleus muscles were secured in pairs onto the mounting blocks and fixed in the
dynamic loading setup. Samples (n=5) were cyclically loaded for 80 minutes by a
sinusoidal positional profile with a peak-to-peak displacement that stretched the muscles
between 0% and 20% strains at a frequency of 3Hz. Loading was performed while the
samples incubated in 16mL of KH solution containing ImM concentration 20kDa FITC-
dextran (Sigma, Catalog # FD20). The drug source was oxygenated with 95% 02/5%
CO2 at room temperature and kept well-mixed by a magnetic stir bar and the motion of
the mounting blocks.
Samples in the control group were secured onto the mounting blocks in the fixed
assembly and incubated for 80 minutes at nominal length in 16mL of KH solution
containing 1mM concentration 20kDa FITC-dextran that was oxygenated with 95% 02/
5% CO 2 at room temperature. The source was kept well-mixed by a magnetic stir bar.
The fluorescence intensity of the dextran bulk source was sampled (1001l, n=6) at
the beginning and end of a representative 80-minute incubation and quantified using a
ThermoLabsystems Fluoroskan Ascent® FL microplate fluorometer (ex: 485nm / em:
538nm).
3.3.3 Tissue Processing and Measurement of Drug
Drug penetration and distribution in the soleus tissue was quantified using
epifluorescence microscopy. After mechanical loading, tissue samples were removed
from the dextran bath, rinsed twice in 15mL of fresh KH to remove surface drug, and
snap-frozen at nominal length while mounted on the static assembly in Isopentane chilled
to -145 0C in liquid nitrogen. 8pm thickness axial cross-sections from the midpoint of the
soleus samples were cut using a Leica CM1850 cryotome. FITC-dextran in tissue
sections was visualized and imaged using an upright epifluorescence microscopy system
(Leica DMRA2 Microscope, 50X magnification, Hamamatsu ORCA 286 Digital CCD
Camera, Metamorph Version 6.3 Software), exciting with a 450-490nm bandpass filter
and collecting with a 515nm longpass filter. Image intensity values were analyzed using
Matlab. The intramuscular penetration depth of dextran from the planar and curved
surfaces of the muscle was defined as the perpendicular distance from the surface at
which fluorescence intensity in the muscle decreased to 5% of the intensity found at the
muscle surface. An initial calibration curve correlating fluorescence intensity in images
with equilibrium drug concentration in the tissue was generated prior to quantifying
penetration depth. Tissue samples (n=6) were incubated to equilibrium in 0.01mM,
0.1mM, or 1mM bulk source concentrations of 20kDa FITC-dextran. Fluorescence
intensity measured in images of 8pm thickness sections of these incubated tissues were
correlated to the drug concentration in the tissue. Tissue concentration was determined
by calculating the product of the bulk source concentration and the fractional volume of
distribution of dextrans in soleus muscle.
4. RESULTS
4.1 System Compliance
The displacement measured by the internal position sensor of the linear motor
tracks one lateral side of the dynamic mounting assembly, which is half of the total
displacement of the mounting blocks in the symmetric loading configuration. Thus, the
total mechanical compliance of the series combination of motor, rack and pinion
assembly, and mounting blocks is the ratio of twice the measured displacement over the
measured force. Total compliance was less than 0.0057 ± 0.002 mm/N and linear over a
broad force range (Figure 6).
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Figure 6. System compliance. Compliance is the slope of the relationship between the
displacement and force produced by the motor. Total mechanical compliance of the
dynamic loading assembly from motor to muscle sample is equal to twice the slope because
of symmetrical displacement of the mounting blocks.
4.2 Motor Tuning
The peak sinusoidal displacement (0.35mm, 3Hz) used oscillates a single lateral
aspect of the symmetrical mounting assembly with a peak-to-peak displacement of 2.5%
strain for a soleus muscle that is 28mm in length. This corresponds to a total cyclic strain
of 5%. The optimal PID parameters that gave the least positional tracking error and
instability were, P: 3.5A/mm, I: 2.005A/(mm*s), and D: 4.005A*s/m. The feed-forward
(FF) friction coefficient, which was programmed based on estimated friction coefficient
of the system, was 0.234A. These settings enabled the muscle to track displacement in
phase with the reference profile and without significant positional error (Figure 7). Over
a 0.7mm peak-to-peak displacement of the motor, the positional error for our upper
bound performance profile was +60gim. These PID parameters and FF friction
coefficient were used for all subsequent loading experiments.
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Figure 7. Motor response under maximal performance requirements. Dynamic
performance of the motor was measured as it imposed a 0.35mm amplitude, 3Hz sinusoidal
positional reference profile on a pair of mounted soleus samples. Response of the motor
was optimized for this maximal performance reference profile by tuning the PID controller
so that A) the actual position of the motor tracked closely to the reference profile and B) the
error between the actual and reference positions was minimized.
4.3 Architectural Integrity
From preliminary incubation experiments, the interstitial space, or tissue porosity,
as a percentage of the cross-sectional area of the tissue, was found to increase linearly
with time up to 24 hours for muscle samples incubated in vitro without mechanical
loading. One hour provided a duration of drug delivery long enough to enable drug
penetration to be significant and quantifiable, as well as for differences in transport under
different loading conditions to be differentiable. Thus, transport experiments were
limited to one hour to limit the extent that structural integrity, and thus the drug transport
environment, would be degraded from the physiologic state. Soleus muscle was assessed
histologically to evaluate changes in tissue architecture as a result of different mechanical
conditions applied in vitro. Control groups included tissues that were snap-frozen
immediately after isolation (0 minutes) and tissues snap-frozen after 70 minutes of no
mechanical loading (0% static strain, 70 minutes). Tissue porosity was quantified at both
the superficial or peripheral edge of the tissue, where drug transport occurs, and at the
central portion of the muscle cross-section (Figure 8).
Porosity of unloaded freshly excised tissue was -1 1%. This value is in agreement
with inulin distribution space, which characterizes the percentage volume of extracellular
space, in rat soleus found by previous studies [39-41]. 70 minutes of in vitro exposure,
whether in the presence or absence of mechanical loads, did not significantly increase
porosity in the central portion of the muscle above the 11.6 ± 5.7% found in the 0-minute
control (p>0.82, Single Factor ANOVA), but it significantly increased porosity at the
tissue edge. Porosity at the tissue edge increased by 1.5-2.2 fold above the 11.1 ± 3.3%
found in the 0-minute control (p<0.015, t-Test) to an average of 21.0 ± 6.1% for all 70-
minute groups. The porosity respective to each region of the muscle was statistically
identical in all mechanically strained groups, which were loaded for 70 minutes (p>0.46
and p>0.92 at the edge and center, respectively, Single Factor ANOVA).
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Figure 8. Tissue integrity. Porosity was measured after different incubation times and
various regimens of static and dynamic strain. Static strain held muscles at 0%, 5%, 10%,
and 15% strain for 70 minutes. Dynamic loading cyclically imposed ±2.5% strain at 3Hz
about 5%, 10%, and 15% mean strains for 70 minutes. Porosity respective to the tissue
edge or center was consistent among all samples incubated in vitro for the same duration,
regardless of the nature of imposed strain, demonstrating that time was the predominant
factor in affecting changes in porosity. Porosity increased at the edge of the tissue relative
to the central portion of the tissue after 70 minutes in vitro.
4.4 Functional Viability
Muscle samples fixed at nominal length maintained isometric twitch contractile
activity at a rate of 3Hz for at least 1 hour. Isometric twitch force from a single soleus
measured every 15 minutes yielded a minimum of 0. 19N for at least 2 hours.
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4.5 Force-Length Relationships
The classic curvilinear, or exponential, increase in passive tension with increasing
stretch that characterizes the passive extensibility of skeletal muscle was observed
(Figure 9). When the soleus was mounted on the fixed assembly, the nominal length of
the muscle was the length at which the first passive resistance to stretch could be
measured. Developed active force, or twitch tension, was obtained as the difference
between the total and passive forces and demonstrated the classic parabolic force-length
relationship.
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Figure 9. Force-length relationships of the soleus. Passive and total forces of the soleus
were measured at 0%, 5%, 10%, 15%, and 20% strain. A) Total, active, and passive
tension of a single soleus muscle (n=7). Active force is produced by isometric twitch
contraction. It is the difference between total and passive force. B) Isometric twitch tension
of 7 different single soleus samples.
Active twitch tension developed in single soleus samples averaged across 7 rats
increased with increasing strain from 0.24 ± 0.06N at nominal length, to a maximum of
0.35 ± 0.06N at 10% strain, and thereafter decreased with further increase in length to
0.19 ± 0.06N at 20% strain. Twitch tensions developed at different strains in both the
increasing and decreasing halves of the parabolic force-length relationship were
statistically significantly different from each other (Single Factor Anova). Peak twitch
tension was in agreement with values obtained in prior in vitro and in situ studies using
rats of similar size [42, 43]. The passive force of 0.12 ± 0.06N developed at the optimal
muscle length where peak twitch tension occurs also agrees with that determined
previously by others [43].
4.6 Fractional Volume of Distribution
The time for both uptake and elution of FITC-dextran (Figure 10) in soleus
samples to reach equilibrium was approximately 28 hrs. Subsequently, incubation and
elution equilibration times used in determining fractional volume of distribution were
limited to 28 hours.
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Figure 10. Incubation and elution equilibrium times. A) Plot of tissue concentration vs.
time quantifies the uptake of drug in soleus samples incubated in bulk dextran sources of
0.1mM and 1mM concentration. B) Concentration of the bulk phase vs. time during the
elution of dextran from soleus samples pre-incubated in 1mM dextran source. Incubation
and elution equilibration times were both approximately 28 hours.
Fractional volume of distribution of dextran in the soleus was quantified over bulk
source concentrations of 0.1 M, 1gM, 0.01mM, 0.1mM, and ImM 4kDa FITC-dextran
(Figure 11). Across this range of bulk concentrations, the equilibrium distribution
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relationship showed a linear trend with a slope of 0.84, indicating a fractional volume of
distribution of 84% available in the tissue for the source concentration of drug. Using an
equilibrium distribution analysis [44], bound fraction of dextran was calculated by
subtracting the product of (slope x bulk phase concentration) from the tissue
concentration. This demonstrated a spread about zero across the entire range of source
concentrations, indicating that binding site density in the soleus was lower than the
scatter in the data at high bulk phase concentrations, and therefore insignificant.
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Figure 11. Equilibrium distribution measurements. Equilibrium tissue concentration is
plotted against bulk source concentration. A) The measured equilibrium distribution
relationship for dextran in soleus muscle. The equilibrium concentration of 4kDa FITC-
dextran in the tissue over a range of bulk source concentrations (0.1pM - 1mM) follows a
linear trend. Fractional volume of distribution, determined by the slope of the equilibrium
relationship, is 0.84. B) Bound concentration of dextran in the soleus. A spread about zero
across the range of source concentrations suggests that binding site density in the soleus for
dextran is insignificant.
Individual ratios of tissue to bulk concentration that are higher than 0.84, as found
in incubation studies (Figure 10), may be attributed to loss of tissue integrity, and
therefore increase in porosity, over 28 hours. Since all samples in this study were
incubated for 28 hours, and therefore tissue integrity was consistent among all samples
across the range of bulk source concentrations, elevation of individual ratios may
uniformly offset the entire distribution relationship to higher tissue concentrations but
does not affect the slope of the relationship or the fractional volume of distribution of
84%.
4.7 Measurement of Drug
A calibration curve relating fluorescence intensity to equilibrium drug
concentration in soleus tissue was generated from epifluorescence images of soleus
samples that equilibrated in 0.01mM, 0.1mM, 1mM bulk concentrations of 20kDa FITC-
dextran. Tissue concentration was calculated based on the finding that fractional volume
of distribution in the soleus was 84% of the bulk source concentration of dextran. An
exposure rate for imaging was chosen that eliminated tissue autofluorescence and
avoided saturation of the intensity detection ability of the imaging system by the source
concentration of drug. Drug source concentrations and intensities represented the range
used in our drug transport studies. The relationship between fluorescence intensity and
tissue concentration was linear over this range of bulk source concentrations (Figure 12).
This is in accordance with the linear relationship between fluorescence intensity and
concentration described by Beer's Law for very low concentrations, I=eCQ, in which I is
fluorescence intensity, e is the molar absorption coefficient, C the molar concentration,
and Q the quantum yield [45].
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Figure 12. Fluorescence intensity vs. equilibrium tissue concentration. Tissues were
equilibrated in 0.01mM, 0.1mM, and 1mM bulk concentrations of 20kDa FITC-dextran and
imaged by epifluorescence microscopy. The fluorescence intensity vs. tissue concentration
follows a standard linear relationship.
4.8 Drug Transport Under Mechanical Loading
In impact of mechanical loading on dextran penetration and distribution in soleus
muscle was investigated by applying either static or cyclic strains on samples while they
incubated in a 1mM concentration 20kDa FITC-dextran bath. Epifluorescence images of
axial cross-sections from the midsection of the soleus muscle were taken, and drug
penetration depth was measured at the planar and curved surfaces of the muscle (Figure
13). Planar surfaces are the dorsal and ventral surfaces of the tissue, and curved surfaces
are the medial and lateral margins of the muscle. Surfaces are referred to as top, bottom,
left, and right based on their location in fluorescent images. Penetration was equivalent
at the opposing planar surfaces (top and bottom) for each loading condition. Penetration
at the planar surfaces averaged 0.52 I 0.09mm under static strain and 0.81 ± 0.09mm
under dynamic strain (Figure 14). Similarly penetration was equivalent at the opposing
curved surfaces (left and right) for each loading condition, averaging 0.82 ± 0.19mm
under static strain and 2.1 ± 0.24N mm under dynamic strain. Penetration at curved
surfaces was significantly higher than at planar surfaces by a factor of 1.57 and 2.52
under static and dynamic strain, respectively. Penetration at both groups of surfaces was
significantly higher under dynamic loading than under static strain. Dynamic strain
increased penetration at curved surfaces to a greater extent than at planar surfaces by a
factor of 1.6 - while penetration increased by a factor of 1.56 at planar surfaces, it
increased by a factor of 2.51 at curved surfaces. Bulk source concentration, quantified by
the fluorescence intensity of bulk source samples taken at the beginning and end of the
incubation period, remained the same throughout the experiment (Figure 15).
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Figure 13. Quantification of fluorescent drug. Distribution of drug in soleus muscle was
qualitatively assessed. Penetration of 1mM concentration 20kDa FITC-dextran into soleus
muscle was quantified in axial cross-sections of the soleus using epifluorescence imaging.
Raw images of fluorescence (images on the left) were converted to intensity values (images
on the right) and analyzed in Matlab. Penetration depth from the surface of the muscle was
quantified as the distance into the tissue at which fluorescence intensity decreased to 5% of
the source intensity at the surface. Penetration was measured at the curved surfaces
(designated Left and Right) and planar surfaces (designated Top and Bottom).
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Figure 14. Impact of mechanical loading on drug transport. The effects of static and
dynamic stretch on the penetration of FITC-dextran in soleus muscle were measured.
Samples were loaded for 80 minutes while incubating in 1mM bulk concentration 20kDa
FITC-dextran. Drug penetrates further into the muscle at curved (left, right) surfaces than
at planar (top, bottom) surfaces. Dynamic strain increases the penetration of drug at both
planar and curved surfaces. Penetration at curved surfaces increases to a greater degree,
by a factor of 1.6, than at planar surfaces under dynamic loading.
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Figure 15. Constant drug source. Fluorescence intensity of the bulk source measured at the
beginning and end of an 80-minute incubation of a pair of soleus muscles undergoing
mechanical loading. Fluorescence intensity, and therefore drug source concentration,
remained the same throughout the incubation of the specimens.
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5. DISCUSSION
The aim of this work was to determine whether dynamic mechanical strain affects
the intramuscular transport of locally delivered drug. To date much of the work on
transport through muscles has focused on measuring changes in interstitial water
distribution, total tissue volume, or extracellular space induced by strain or contraction
using tritiated water [39]; molecular markers like inulin [39, 46, 47]; albumin [48, 49]; or
solutes like EDTA [48], sodium, and potassium [1, 50]. A few studies have measured
contraction-induced diffusion of water [51] or myoglobin [52] in single muscle fibers.
And many other studies have focused on how strain or contraction in whole muscles
affects the total uptake of metabolic substrates like glucose [9, 10, 23, 53-55], lactate
[56], phosphate [57], calcium [26, 58], and sodium [59]. However, no investigations to
date have quantified the isolated effects of different mechanical loading regimens on the
extracellular spatial distribution and transport, not just total uptake, of a drug in muscle
tissue. With the advent of local drug delivery to contracting structures, the impact of
static as well as cyclic and dynamic strain is critical to a complete understanding of
intramuscular pharmacokinetics and pharmacodynamics. Our current studies
investigated the local pharmacokinetics of muscle under static and cyclic mechanical
loading. These studies required careful preservation of natural muscle dimensions and
contractile function, the ability to apply controlled strain and variable concentrations of
drugs within pharmacologic ranges directly to the target tissue, and continued
maintenance of tissue integrity and viability. We therefore designed and implemented a
surgical isolation and mounting technique, as well as a mechanical loading system, that
achieved these goals.
5.1 Design of a New Biomechanics Preparation and Mechanical Loading System
Most preparations used in current studies of passive material properties or
contraction mechanics of muscle disrupt the physiologic anatomy and mechanical
function of the tissue specimen. The method for securing muscle samples in a
biomechanics preparation, especially one for investigating drug transport, is critical for
the investigation of accurate mechanical properties and drug transport. Strain conditions
applied to a muscle bundle during mounting or suspension can introduce various loading
artifacts that alter the structure and function of the muscle, as well as disrupt drug
transport. Suture ties or piercings, using thread or steel wire, may quickly grip and
suspend tissue in a diverse set of configurations, but do so without constraint of axial
rotation of the muscle. Such rotational freedom allows unwanted torsional distortion of
muscle architecture during tensile strain or contraction. Sutures also increase the
compliance of a tensile system, which affects both force transmission and measurements.
Moreover, as with the application of clips or clamps, compression and disruption of the
extremities of the tissue by suture ties or piercings introduce stress concentrations and
local disruption of muscle architecture that can create drug transport artifacts. Hooks and
pins employed at either the tendon or muscle body are even simpler to apply than sutures,
but they more significantly physically disrupt the tissue and interrupt the integrity of the
architecture and the normal distribution of transmitted forces. Fixing rods provide more
stable support if used with an intact bone segment and can potentially fix the ends of the
muscle without distortion of the soft tissues but do not provide secure fastening points to
constrain the muscle in a physiologic orientation. To our knowledge, few studies have
considered more rigorous techniques of securing muscle by bone attachments [60-62],
and none have presented a preparation specifically designed to maintain an isolated
muscle in an architecturally physiologic configuration for appropriate force transmission
throughout the entire muscle unit, from muscle to bone. In this study, we presented a
surgical technique and loading preparation that secures whole soleus samples, eliminates
loading artifacts, and preserves physiologic architecture, configuration, and
architecturally dependent force transmission - all of which directly influence
intramuscular drug transport.
5.1.1 Tissue Isolation and Mounting
Our isolation and mounting methods are robust enough to extend to examination
of general biomechanics. The tissue isolation, explantation, and preservation protocol
can be applied to any study or preparation investigating mechanical, physiological,
biochemical, or molecular properties of muscle. The mounting technique and device are
applicable in any setup or preparation in which isolated muscle is to undergo either static
or cyclic tensile strains or forces. These include studies of not only externally applied
loads, but also contractile function under electrical as well as chemical stimulation in
which muscles generate force, displacement, or velocity. Our mounting blocks can be
used independently in a dedicated fixed, or static, assembly for applying static strain or
load, securing tissue, or tracking electrophysiologic responses. The static assembly can
be configured for force measurements with the attachment of a load cell or force
transducer. The mounting technique, and even the blocks themselves, can be
incorporated as the fixturing method in existing in vitro or in situ physiology,
biomechanics, or electrophysiology preparations for applying dynamic loads; or
measuring passive and active tensile force, strain displacement, or velocity under external
loading or stimulated contraction.
With their robust design, the isolation and mounting methods especially enable
effective local drug delivery and transport studies to be performed. In any application,
the surgical isolation protocol eliminates trauma to the soft tissues and maintains intact
muscle, tendons, and bone attachments to allow more physiologic mechanical properties
to be preserved. By the nature of their design, the mounting blocks can be applied to
muscle specimens as quickly as, or quicker than, applying sutures, hooks, or clamps, but
without the risk of slippage of the specimen. Angled slots in the blocks secure specimens
by mechanical fit and leverage of the bone segments, which eliminate the need for
additional fastening mechanisms. Mechanical fit prevents slippage and rotation of the
specimen, and leverage on the bones enables them to transmit tensile forces to the
tendons and muscle. By the mechanical mechanisms they use to restrain the bone, the
mounting blocks maintain the physiologic configuration of suspended muscle specimens,
and thereby eliminate artificial stresses and trauma to the muscle and tendons that are
typically introduced by current mounting methods and are potential sources of drug
transport artifact. In this manner, these techniques are optimal for the rigorous tissue
handling requirements of studying accurate drug transport. Whether used in primary
biomechanics studies or within the context of a another muscle physiology investigation,
the ability of these techniques to accurately load samples in a physiologic mechanical
configuration is a valuable tool for investigating muscle in an in vitro or in situ setting,
separate from in vivo work.
5.1.2 Dynamic Loading System
The dynamic loading system, which can incorporate the individual mounting
blocks of the static assembly as its mounting fixtures to secure muscles in a physiologic
configuration, enables mechanical loading of muscles with a broad range of dynamic
functionality. The test instrument combines precise, feedback-controlled, mechanical
loading that is driven by a linear motor at 20tm positional resolution, with versatile,
computer-automated loading profiles that span a diverse range, from continuous cyclic
strains to user-defined displacement profiles. The setup can be oriented either vertically
or horizontally, incorporate force transducers or load cells, and accommodate different
motors.
The loading system was designed as a means to examine drug delivery and
transport. The device allows for either static or dynamic mechanical loading to be
conducted on mounted samples while they are immersed in a media bath under
physiologic conditions. This functionality enables biomechanics testing to be performed
in vitro without loss of tissue integrity or mechanical function. Moreover, this
functionality enables the preservation of muscle structural dimensions and functional
viability, control of the local environment, and effective investigation of intramuscular
transport of agents locally delivered directly to the samples by the bath. The compact
design of the system makes it suitable for incubator use to perform in vitro testing under
more precise temperature and environmental control. The ability for the system to
effectively perform biomechanics testing on muscle samples that are suspended under
mechanically and environmentally physiologic conditions not only introduces a new
realm for investigations of tissue pharmacokinetics, but also opens up new opportunities
for biomaterials testing under axial loading. With the incorporation of proper mounting
fixtures, these studies could be expanded beyond skeletal muscle to include arterial or
myocardial tissues, as well as ligament, tendon, cartilage, and engineered tissue
constructs.
5.2 System Validation
We validated the dynamics of our loading system, tissue preservation capacity of
our drug delivery preparation, and ability to track drug transport after local drug delivery
to soleus muscles under mechanical loading.
5.2.1 Dynamic Loading
As the total compliance of the loading system is less than 0.0057 ± 0.002 mm/N,
our system can apply a greater range of static or dynamic load without loss of strain or
displacement compared to other systems developed to apply high frequency vibrations
concurrent with larger amplitude elongation, or small length perturbations, which have
2.5 to 116 times greater compliance [13, 34, 63, 64]. In return, the lower compliance of
our system enables examination of a greater range of static or dynamic strain without loss
of force transmission to the specimen. Linearity of the relationship between force and
displacement demonstrates a constant compliance in the system and allows for simple
correction for "series compliance" during biomaterials characterization.
5.2.2 Tissue Preservation
Along with characterizing the performance of the loading system, we examined
the tissue preservation capacity of our drug delivery preparation. As a measure of tissue
preservation, we assessed architectural integrity of soleus muscle samples. Architectural
integrity is particularly important for drug transport studies because porosity, or
interstitial space, defines the intramuscular accessible space available for transport of
soluble dextran, which exhibits bulk uptake (i.e. the uptake increases linearly with bulk
source concentration) and transports in the extracellular space [65-67]. Thus, changes in
tissue porosity would dramatically affect drug transport.
Characterization of tissue porosity in the soleus suggests that changes in structural
integrity experienced by the muscle in vitro during our transport studies occur at the
peripheral edge of the specimens and are consistent among all samples incubated for the
same duration, independent of the nature or range of mechanical loading. While
mechanical loading expectedly influences structural configuration when applied on a
specimen, it is the duration of time the specimen spends in vitro that is the predominant
factor affecting progressive and permanent changes in tissue integrity and porosity. This
finding suggests a time-dependent degradation of the tissue, starting at the peripheral
edge, which progresses linearly with time, based on preliminary findings, throughout the
incubation period. Peripheral changes may arise from a multitude of effects including
greater exposure and loss of protein substrate to the superfusate and absence of
circumferential support from adjacent muscle fibers. Anoxic degradation is common for
in vitro preparations but is unlikely in this case as the peripheral edge of the muscle was
in direct contact with oxygenated solution, and architectural integrity of the deeper,
central region was approximate to freshly excised specimens, suggesting that there was
adequate oxygenation throughout the entire tissue. Consequently, as all specimens in our
transport experiments are incubated for the same duration, the peripheral tissue
architecture where drug transport occurs can be considered consistent among specimens
across all loading groups, whether loading is static or dynamic. Any differences
observed in transport can be attributed to the influences and dynamics of mechanical
loading rather than differences in porosity resulting from tissue injury or degradation.
Despite porosity changes at the tissue edge, tissue viability was still preserved as
architectural integrity at the center of the tissue remained intact, and functional integrity
was still retained as demonstrated by continuous twitch activity for 1 hour under maximal
performance conditions (3Hz contraction rate) and the preservation of active force
production (at least 0.19N) for at least 2 hours.
The force-length characteristics of the intact muscle-tendon unit were measured.
However, tendons, which consist of dense connective tissues, exhibit minimal length
extensibility characteristics and can be considered to have constant length within a
physiological range of strain [22, 68, 69]. Thus, the measured passive force-length
relationship of the muscle-tendon unit reflects the passive viscoelastic material property
of the muscle, which is well described in the classic biomechanics literature. As a
comment on nomenclature used in these studies, because the peak of active force
developed by stretched muscles occurs at 10% strain, the muscle length referred to in this
study as 10%0/ strain is equivalent to what is traditionally defined as the optimal or resting
length, Lo, the length at which maximal active force is developed. Furthermore, because
the nominal in situ length, or 0% strain, is the length at which passive force developed
during stretch can first be measured, the muscle length referred to in this study as
nominal length is equivalent to what is traditionally defined as the initial length, the
length at which the first passive resistance to stretch occurs. Accordingly, 0% to 20%
strains in this study span the mid-range muscle length, or the physiologic range of muscle
extensibility, and do not approach the muscles' maximum length, the length beyond
which further stretch results in rupture of muscle fibers. Thus, transport studies
conducted within this range of strain will accurately capture the target tissue environment
under physiologic lengths and active forces.
5.2.3 Quantification of Drug Transport
Linearity of the relationship between fluorescence intensity and tissue
concentration demonstrates a range of drug source concentrations that enables accurate
detection of drug in the tissue that is unaffected by tissue autofluorescence, fluorescence
quenching, or intensity saturation of the fluorescence imaging system. Furthermore,
linearity enables easy conversion between dimensionless fluorescence intensity values
and drug concentration in the tissue. As a result, quantification of drug penetration depth
in the muscle can be performed using the actual fluorescence intensity values directly
from an image without the prior need to convert such values to tissue concentrations,
which could introduce conversion deviations. Thus, this quantification method is an
effective and direct way to not only measure drug uptake, but also to visualize the
intramuscular spatial distribution of fluorescent drug.
5.3 Intramuscular Pharmacokinetics
5.3.1 Equilibrium Distribution of Drug
Dextrans are hydrophilic polysaccharides characterized by high water solubility,
stability in solution, extracellular transport, inertness, and non-protein-binding properties
[65, 67, 70]. Furthermore, dextrans are stably conjugated with fluorescent labels like
fluorescein isothiocyanate (FITC) under in vivo and in vitro conditions [71]. Our tissue
incubation studies validate the bulk uptake characteristics of FITC-dextran transport in
soleus muscle. Equilibration time for both incubation and elution of dextran from soleus
samples was 28 hours. Equivalent uptake and elution times suggest that any interaction
or binding between dextran and cell surface or extracellular matrix binding sites in the
target tissue has equivalent tissue-average association and dissociation kinetics, and is
therefore non-specific and likely insignificant in nature.
The absence of significant specific binding allows soluble dextran to diffuse or
convect through the intramuscular accessible space without the impediment of drug-
tissue interactions. This characteristic is verified by our finding of an equilibrium
distribution relationship that is linear over 4 orders of magnitude of bulk phase source
concentrations (0.1 gM - ImM). A linear relationship signifies bulk uptake of dextran, or
uptake that increases linearly with bulk source concentration.
The presence of a significant binding density, however, would present a saturable
component to the uptake characteristic that would introduce a noticeable nonlinearity in
the equilibrium distribution relationship at low source concentrations (Figure 16). A
significant binding capacity that sequesters soluble drug would not only increase total
drug uptake by a capacity equivalent to the density of binding sites in the tissue, but also
increase the fractional volume of distribution, or slope of the equilibrium distribution
relationship, starting at low drug concentrations until saturation of the binding sites is
reached. Linearity of our measured distribution relationship across a broad range of
concentrations demonstrates that specific binding is not present. Moreover, the bound
fraction of dextran that is calculated using the equilibrium distribution analysis is spread
about zero across the entire range of bulk source concentrations. This indicates that the
binding site density for dextran in the soleus, which is lower than the scatter in the data at
high bulk phase concentrations, is insignificant.
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Figure 16. Equilibrium distribution model. This is a model of drug distribution through
tissues incubated to equilibrium in bulk phase concentrations of drug [44]. The total
concentration, which is measured empirically, is the sum of the bound and soluble fractions.
The soluble concentration increases linearly, at a rate or slope of e, with increasing source
or bulk phase concentration. The bound fraction increases the capacity of total drug
uptake. Binding increases the slope of the total equilibrium relationship at low
concentrations up to the saturation density of binding sites in the tissue, as shown by the
dashed line. A significant binding capacity will therefore introduce nonlinearity in the total
equilibrium distribution relationship.
A linear relationship further signifies that the highest bulk source concentrations
used in our studies do not saturate the total uptake capacity of the tissue for soluble
dextran. Excessively high bulk concentrations would result in a total equilibrium
relationship that asymptotes to a saturation limit at high bulk concentrations. Therefore,
linearity of the measured distribution relationship over the range of source concentrations
used in our studies enables us to investigate drug transport that is unaffected by either
specific drug-tissue interactions or capacity limitations of the tissue, which could
potentially impede drug transport through sequestration or influence the driving force for
drug penetration through tissue-induced gradients in drug concentration.
A fractional volume of distribution of 84% further supports the uninhibited
transport characteristic of dextran in the tissue. Based on the equilibrium distribution
model [44], the fractional volume of distribution is the empiric ratio between the
concentration of soluble drug per unit total tissue volume and the concentration of the
bulk phase. This relationship reflects the influences of steric interactions in the tissue
that may exclude soluble drug and any charged partitioning in the accessible space that
may reduce the concentration of soluble drug in the tissue. The fact that fractional
volume of distribution is near 100% suggests that there is minimal inhibition, in the form
of steric hindrance or partitioning, of dextran to freely diffuse through the muscle.
Therefore, the concentration of dextran that transports within the accessible volume of
the muscle closely approximates the concentration of dextran from the bulk source. This
inert characteristic of dextran makes it an ideal, fluorescently labeled molecule to use in
our experiments to investigate drug transport that is independent of specific binding.
As a matter of clarification, the fractional volume of distribution is distinct from
the fractional volume, which is the ratio of accessible volume in the tissue to total tissue
volume. Whereas fractional volume of distribution defines an effective drug transport
space, fractional volume is a literal, physical space reflected more appropriately by tissue
porosity. As a result, the soleus can have a fractional volume, or porosity, of 11%, as
shown by our tissue integrity studies, and also have a fractional volume of distribution of
84% for drug transport.
5.3.2 Drug Penetration and Distribution Under Mechanical Influence
5.3.2.1 Validation ofExperimental System
Visual quantification of intramuscular drug transport gave us insight into the
penetration and distribution of drug in soleus muscle and enabled us to evaluate the utility
of our experimental system and measurement protocol. Drug penetration and distribution
in incubated muscles was directly quantifiable from fluorescent images (Figure 13).
Measurements made using these images had enough precision and consistency over
multiple samples to show statistically significant differences in transport between loading
groups.
Equivalent penetration at opposing planar and curved surfaces suggests that there
is no directional preference to transport imposed by tissue architecture in either the
dorsal-ventral or medial-lateral orientation. It suggests homogeneity of morphology with
respect to each orientation, but not necessarily an overall isotropy for drug transport in
the entire tissue. However, an isotropic transport environment may be assumed based on
histological assessment. Additionally, equivalent penetration at opposing surfaces, or
symmetry of penetration into the tissue, simplifies quantification of drug penetration in
tissue images and serves as a measure of consistency of drug transport in each sample.
Penetration can be quantified using either one of the opposing surfaces from either
orientation. However, transport at the planar surfaces proceeds unidirectionally into the
muscle and exemplifies transport into a semi-infinite medium as penetration does not
reach the half-thickness of the tissue within the duration of our experiments. Thus, drug
penetration can be more consistently quantified and analyzed if measured from the planar
surface.
Lastly, as drug source concentration was constant throughout the duration of the
experiment there was no significant depletion of drug by the mass of the exposed muscles
(Figure 15). Consequently, the driving force for drug penetration into the tissues was
constant throughout the incubation period. These findings validate the precision and
repeatability of the isolation and mounting technique, loading system, drug delivery
preparation, and fluorescence quantification protocol.
5.3.2.2 Drug Penetration and Distribution
Muscle architecture and geometry play in important role in the intramuscular
distribution of drug. Penetration at the curved margins of the soleus was greater than at
planar surfaces by a factor of 1.57 under static strain and 2.52 under dynamic strain
(Figure 14). Assuming an isotropic transport environment in the muscle, greater
penetration at the curved margins may result from both the geometry of the curved
surface itself and the spatial edge effect of drug distribution and penetration occurring at
the margins of a nearly flat muscle cross-section. Substantial curvature of the marginal
surface results in a semi-circumferential exposure to drug, which increases the surface
area for drug to enter at this region and enables penetration to proceed in a multi-
direction maimer. Furthermore, drug transporting from these curved margins readily
encounters drug penetrating at the planar surfaces due to the flatness and elliptical
geometry of the muscle cross-section. Thus, drug penetration at the planar surfaces can
contribute significantly to the distribution of drug at the curved ends, especially when
penetration is enhanced at all surfaces by mechanical loading.
5.3.2.3 Impact ofDynamic Loading
Dynamic loading impacts the penetration and distribution of drug in skeletal
muscle. Cyclic strain significantly increased penetration of dextran into the tissue, by a
factor of 1.56 at planar surfaces and 2.51 at curved surfaces. It is likely that dynamic
loading, which cyclically stretches muscle through a range of strains from 0%-20%, both
modifies the extracellular space available for drug distribution and alters the transport
kinetics of the drug. From our assessment of architectural integrity, permanent changes
to tissue porosity are independent of loading condition. Therefore, it is unlikely that drug
penetration under dynamic loading increases due to progressive and lasting changes in
extracellular space caused by straining the tissue. However, applying cyclical stretch
between 0% and 20% strain may transiently expose drug to strain-dependent architectural
configurations that have a larger accessible volume compared to that of the un-stretched
configuration. Drug access to these larger volumes during a portion of each cycle of
stretch may create spatially and temporally heterogeneous concentration gradients that
increase the diffusional driving force for drug penetration. Moreover, mere exposure to a
larger distribution space during a portion of the loading cycle may result in a greater
time-averaged porosity for drug transport.
Perhaps not only mere exposure to architectural configurations with larger
distribution space, but also the dynamic physical process of transitioning between
different configurations has a great influence on drug transport. The dynamic forces
generated by oscillatory loading may impact transport kinetics and enhance drug
penetration. Oscillatory loading can create dispersive influences [72] on soluble or
aqueous drug that increase transport beyond molecular diffusion alone. Cyclic transitions
between structural configurations during dynamic loading can compress and expand
extracellular space. Such cyclic displacement and deformation of muscle fibers can
impose normal and shear forces on interstitial fluid, resulting in pulsatile movement and
agitation of soluble drug in the absence of bulk convective fluid flow. Such pulsatile
agitation can disperse or spread drug over a greater volume of the available extracellular
space, thereby driving it further into the tissue from the bulk source. As dispersion relies
on the dynamics of structural displacement, it is dependent on the rate of oscillation.
Therefore, dispersion is distinct from the mechanism of transient exposure to different
architectural configurations, which yields the same time-averaged porosity for a single
loading profile regardless of the rate of oscillation. For example, imposing a regular
sinusoidal loading profile that strains the tissue between 0% and 20% would yield the
same time-averaged porosity, whether the frequency was 1Hz, 2Hz, or 3Hz, because the
tissue spends the same portion of each cycle at each strain regardless of the rate at which
it occurs. However, rate of oscillation would modify the dynamics of loading and create
progressively greater dispersive effects with greater loading frequencies.
5.3.2.4 Interaction Between Loading and Architecture
The fact that penetration at the curved margins increases to a greater degree, by a
factor of 1.6, than at planar surfaces with dynamic loading may be attributed to the
combined influence of static structural geometry, as discussed in Section 5.3.2.2, and the
spatially distinct dynamics of strain and extracellular space changes during stretch that
are shaped by such geometry. While no biomechanics studies to our knowledge have
quantified this effect, it is likely that changes in extracellular space and fractional volume
of distribution inside a muscle developed during stretch are spatially heterogeneous and
influenced by the local geometry of the muscle.
The uni-pinnated, parallel-fibered rat soleus muscle has an elliptical axial cross-
section that is observed to flatten and widen when the muscle is stretched. Studies of uni-
pinnated muscle have revealed that they experience changes in geometry during isometric
contractions at various initial muscle lengths that are comprised of spatially
heterogeneous changes in aponeurosis length, angle of pinnation of muscle fibers, and
fiber length [73]. One study observed transverse (perpendicular to the muscle surface)
strains in superficial muscle fibers as the muscle body flattens during isometric
contraction, and that aponeurosis surface area decreases with increasing initial muscle
length [62]. It can be extrapolated from these studies, which assessed strains and changes
in geometry only from the muscle surface, that flattening and widening of the soleus
during stretch translate into similarly heterogeneous internal fiber rearrangements and
intramuscular forces that can alter local drug distribution space and dispersion effects.
This is especially the case when considering that conservation of muscle volume results
in both widening and flattening of the muscle during elongation. While superficial
muscle fibers at the planar surfaces tighten with muscle flattening, those at the curved
margins of the soleus may experience increased outward transverse strains with muscle
widening during stretch. Furthermore, because superficial fibers at the curved margins of
the muscle occur more peripheral to the center of the tissue, they have more obtuse angles
of insertion relative to the muscle axis at the aponeuroses compared to fibers at planar
surfaces, which are located towards the midline. These differences in local muscle
geometry, fiber arrangement, and angle of insertion likely dictate heterogeneous local
strain dynamics and changes in extracellular space during stretch or contraction. These
architectural and dynamic heterogeneities may play a dominant role in producing greater
enhancement of drug penetration at the curved surfaces under dynamic stretch.
Our findings suggest that mechanical loading influences drug transport through
modulating and potentially superposing dispersive effects on the existing framework of
drug transport established and dictated by tissue architecture.
5.4 Conclusions
This study presented a surgical isolation and muscle mounting method that
preserves physiologic architecture of small rodent soleus muscles. A robust mechanical
loading system and intramuscular fluorescent drug measurement protocol were also
presented. These techniques were applied and validated through an experiment that
investigated intramuscular transport of soluble macromolecule drug under mechanical
loading of the tissue. The results from this experiment demonstrated the influence of not
only architectural geometry and configuration, but also mechanical loading on
intramuscular drug transport and distribution. Consequently, this work demonstrates the
power and necessity of careful tissue isolation and mounting to maintain the physiologic
configuration of samples. Significant findings from our work are that dynamic
mechanical loading increases drug penetration into muscle above that achieved by static
suspension of the muscle at nominal length, and it impacts drug distribution in muscle.
These findings yield important implications for pharmacokinetics investigations and
clinical drug delivery strategies. Such studies should rightly consider the motion and
contraction of a target tissue as drug transport is investigated. In particular, such studies
should be conscious of the pharmacokinetic impact of mechanical loading and
architectural physical activity of muscle target tissues, whose physiologic operational
domain is mechanical activity.
6. FUTURE STUDIES
The influence of mechanical loading on transport is a new insight into tissue
pharmacokinetics that requires further investigation. Further pharmacokinetics
investigations using this test system and protocol have been planned to determine the
isolated effects of different mechanical loading regimens on drug penetration and drug
distribution profile.
6.1 Static Strain
These studies intend to quantify the effect of various degrees of static tensile
strain on drug penetration to identify the distinct influence of architectural configuration
and strain-dependent extracellular space on transport. Muscle morphology at these
various strains will be quantified and correlated to drug penetration.
6.2 Drug Physical Property
In addition to studying target tissue structure, the influence of drug physical
properties oi1 transport will be investigated by comparing penetration of dextrans of
various molecular weights at various static strains.
6.3 Dynamic Strain
The distinct contribution of oscillatory forces, independent of architectural
configuration, will be investigated by quantifying drug penetration under various
frequencies and durations of cyclic loading over a range of mean tensile strains.
6.4 Contraction
In contrast to elongating strain, the influence of contraction on drug transport will
be assessed by quantifying penetration under various rates of isometric twitch
contraction.
6.5 Computational Model
Ultimately, these investigations seek to establish a quantitative understanding of
the influence of mechanical loading on transport by synthesizing the findings from these
experiments into a computational model that describes these pharmacokinetic
phenomena.
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APPENDIX A: MATLAB SOURCE CODE TO SIMULATE RESTING MUSCLE
RESPONSES TO LENGTH PERTURBATIONS
Simulation of Step Response
clear
clc
% Parameter Values for Inertial Mass, Muscle Stiffnesses, and Damping
Coefficients
% In SI Units, Newton, Kg, Meter, Seconds
% Amplitude of length perturbation
A=.002; %m
k0=10*9.806658*20; %N/m
k1=3*9.80665*20; %N/m
k2=2.5*9.80665*20; %N/m
cl=.1625*9.80665*20; %N.s/m
c2=6*9.80665*20; %N.s/m
% Time-Domain
Equations
conversion from g/mm to N/m multiplied by
cross sectional area of 20 mmA2
t=linspace(0, 10,100);
first=A*kO;
second=A*kl *exp(-t/(cl/kl));
third=A*k2*exp(-t/(c2/k2));
fp=first+second+third;
max(fp)
plot(t,fp)
title('Passive Tension Response of Muscle to Step Displacement of 0.002m')
xlabel('Time (sec)')
ylabel('Force (N)')
Simulation of Frequency Response
clear
clc
% Parameter Values for Inertial Mass, Muscle Stiffnesses, and Damping
Coefficients
% In SI Units, Newton, Kg, Meter,
Seconds
% Total Mass Estimate of muscle and loading assembly components
m=0.2; %kg
% Model1
Parameters
k0=10*9.806658*20; %N/m
k1=3*9.80665*20; %N/m
conversion from g/mm to N/m multiplied by
cross sectional area of 20 mm^2
k2=2.5*9.80665*20; %N/m
cl=.1625*9.80665*20; O/oN.s/m
c2=6*9.80665*20; O/oN.s/m
% State Space
Model
A=[O (-l/m) (-l/m)
B=[(1/m); 0;0;0];
C=[1 0 0 0];
D=[O];
sys=ss(A,B,C,D);
% Vm/F
Function
sys2=tf(sys);
(-1/m); kl (-kl/cl) 0 0; k2 0 (-k2/c2) 0; kO 0 0 0 ];
in Transfer
% Creation of the Fin/Xm Transfer
Function
den=[5 94.39 38.46 0];
num=[1 18.88 1.521e004 2.316e005 7.544e004 0];
% Maximum
Estimate
%Transfer function
% 5 s^3 + 94.39 s^2 + 38.46 s
%---------------------------------------------------------
%s^4 + 18.88 s^3 + 1.521e004 s^2 + 2.316e005 s + 7.544e004
% Bode Plot of Displacement Input and Force
Output
w=logspace(0,1.3,1000);
bode(num,den,w)
[MAG,PHASE,W] = BODE(num,den,w);
%Multiply the Force by a 20% displacement for a 10mm length of muscle
%or a 2mm length perturbation
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APPENDIX C: MOTOR SPECIFICATIONS
Linmot@ Linear Motor Specifications
Linear Motor LinMot® PO1-37x240/60x260
Servo Controller E100-MT
Power Supply 48VDC, 150W
Peak Force, Fp 120N (271bf)
Continuous Force, Fc 55N (12.41bf)
Limit Force, Fb 72N (16.21bf)
Force Constant, cF 40N/A (91bf/A)
Maximum Stroke, s 260mm (10.2in)
Shortened Stroke, SS 60mm (2.4in)
Zero Position, ZP 75mm (3in)
Max. Acceleration, a 144m/s2 (5700in/s 2)
Max. Velocity, v 1.3m/s (51 in/s)
Position Repeatability ± 0.1mm (+ 0.004in)
Linearity ± 0.3%
Slider Mass, mS 829g (1.831b)
Slider Length, IS 395mm (15.6in)
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Servo Controller:
- Series 1000
supply voltage 72 V DC
phase current 5.0 A
Series 100
supply voltage 48 V DC
phase current 3.0 A
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